Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behavior, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office.
With a 2017 impact factor of 6.544, Neuropsychopharmacology ranks 10th of 142 Psychiatry journals, 13th of 261 Pharmacology and Pharmacy journals, and 21st of 261 Neuroscience journals. 68% of accepted articles are published online in less than 25 business days and in print in less than 111 business days. In 2017, all issues of Neuropsychopharmacology were published on or ahead of schedule.
In 2018, Neuropsychopharmacology (NPP) saw more than 1.5 million page views, and 427,239 new users. Of that, 88% were views of articles (as opposed to the homepage or Instructions for Authors, for example); the average time on an article page was a little over four and a half minutes. In 2018, 43% of users were from the US. NPP also saw 26% of our users visit us from either a mobile device (22%) or tablet (4%). Check us out at www.nature.com/npp!
In view of the interdisciplinary nature of the field, particular emphasis is placed on:
studies that advance the biological bases of normal and pathological behavior
the nature, etiology and pathophysiology of neuropsychiatric disorders
biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders
the basic mechanisms by which psychopharmacological agents exert their effect
Dr. William A Carlezon Jr, Ph.D.
Dr. Gretchen Neigh, Ph.D.
NPP Social Media Editor
Are you receiving Neuropsychopharmacology e-alerts?
Sign up with your e-mail address to receive monthly table of contents alerts and keep informed with Neuropsychopharmacology news and announcements. Each e-alert features the latest journal commentaries, circumspectives, original research and review articles.
Free...Identifying substance use risk based on deep neural networks and Instagram social media data https://t.co/Rt7hUnhxVX #mentalhealth #nppjournal #socialmedia #substanceuse #addiction
E2F3b regulates the mouse PFC transcriptome in a manner similar to cocaine self-administration @hannahmcates @EricJNestler @EAHellerPhD @RCBagot @caseylardner @walkerdm79 @cate_cholamine https://t.co/uVeTNtJ34D #nppjournal #mentalheath #addiction